Antibodies may cut heart attack risk


A pink heart on a blue background

Antibodies could protect against heart attacks, according to a study by researchers from Imperial College London.

The research, supported by the Imperial Biomedical Research Centre and conducted by scientists funded by the British Heart Foundation, studied 10,000 patients with high blood pressure. Of these patients, 87 developed coronary heart disease, and were matched with healthy controls.  The team also studied a further 143 patients who had their heart arteries extensively studied using cutting edge techniques.

We are one step closer to figuring out how the immune system protects from dangerous heart attacks Dr Ramzi Khamis Study author

The study, published in the journal EBioMedicine, revealed that those who had heart attacks in the first study, as well as those whose arteries had unstable fatty plaques (which can rupture and trigger a heart attack) in the second study, had much lower levels of the antibody.

In the first study, those with high levels of the antibody had 70 per cent less chance of developing heart disease over nearly five years of follow up. The second study provided some explanation for those findings, in that those with highest levels of antibodies were well protected from developing dangerous plaques that are more prone to rupturing and causing a heart attack.

The research team, who collaborated with scientists from Lund University in Sweden and Thoraxcenter in Holland, say not only could this finding help doctors more precisely identify patients at risk of heart attack, it also raises the possibility of using therapies that improve the immune system - such as vaccines - to reduce the risk of a heart attack.

The researchers don’t yet know why some people have higher levels of this specific antibody. Although, it may be that some people inherit these protective antibodies, others may have produced them in response to common bacterial infections in childhood.

Atherosclerosis is the build-up of fatty plaques in the walls of the arteries that lead to the brain or heart. If an atherosclerotic plaque ruptures, a deadly blood clot can form and block the blood supply to the heart or brain, causing either a heart attack or stroke. Each year in the UK over 100,000 people die after suffering from these events.

Better treatments

Lead researcher Dr Ramzi Khamis, consultant cardiologist and BHF Clinical Research Fellow at the National Heart and Lung Institute, Imperial College London, said: “We are one step closer to figuring out how the immune system protects from dangerous heart attacks. We hope that our research will help us find patients at the highest risk, as well as help us to develop therapies that target the immune system, which seems to play an important part in preventing heart attacks.”

Dr Noel Faherty, Senior Research Advisor at the British Heart Foundation, which funded the research, said: “Each year in the UK over 100,000 people die from a heart attack or stroke that has been caused by rupture of a fatty deposit, called a plaque, on the inside of an artery. By discovering which patients have plaques that are more likely to rupture and why we can save thousands of lives.

“We already know that our immune system takes part of the blame in causing these fatty deposits to form and rupture. But the whole story of how our immune system is involved in heart and circulatory diseases is a lot more complex. More research is needed, but in the future, we might be able use new drugs to tweak the immune system in different ways to prevent people having a heart attack or stroke.” 


"IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3)" by V van den Berg et al is published in EBioMedicine 



Kate Wighton

Kate Wighton
Communications Division

Click to expand or contract

Contact details

Show all stories by this author


Global-challenges-Health-and-wellbeing, Strategy-collaboration, Research, 4IR
See more tags


Comments are loading...

Leave a comment

Your comment may be published, displaying your name as you provide it, unless you request otherwise. Your contact details will never be published.